Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medtronic Cardiovascular
The primary purpose of this registry is to provide an endovascular means of treatment for those patients experiencing a sub-optimal outcome related to the implanted AneuRx bifurcated stent graft and who are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff. A sub-optimal outcome is defined as either a Type I or Type III endoleak and/or an inadequate seal zone (\< 1 cm). For Registry purposes, a Type III endoleak will be defined as a proximal modular endoleak.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient \>= 18 years of age
Patient has a serious disease or condition
No generally acceptable alternative for treating patient is available
Patient has had the AneuRx stent graft system implanted \>= 30 days
Patient has suboptimal outcome with the AneuRx stent graft system as evidenced by one or more of the following:
Type I endoleak
Type III endoleak (Proximal, modular)
Loss of seal zone
Proximal aortic neck diameter \>= 14mm and \<= 30mm
Angle between axis of the suprarenal aorta and aneurysm neck is \<= 60 degrees
Patient is able and willing to be available for 12,24,26,48 and 60 months post-procedure
You may not be if
Patient is pregnant of lactating
Arterial access cannot be crossed with a delivery system
Excessive vessel tortuosity
Excessive aortic calcification
AneuRx stent graft system implanted within the last 30 days
Clareo Health | Talent Aortic Cuff Stent Graft System Compassionate Use Registry
